Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNA-34 (miR-34) family dysfunction is implicated in various cancers, including non-small-cell lung cancer (NSCLC).
• The specific roles of miR-34 family members in the progression of lung squamous carcinoma (SCC), particularly in occupationally exposed patients, remain unclear.

Purpose of the Study:

• To investigate the expression levels of miR-34 family members in SCC patients.
• To compare the roles of miR-34a and miR-34b/c in SCC progression in vitro and in vivo.
• To explore the relationship between miR-34a, CD44, and SCC development.

Main Methods:

• Comprehensive analysis of miR-34 family expression in SCC patients.
• In vitro and in vivo assays to assess the functional roles of miR-34a and miR-34b/c.
• Investigation of the miR-34a and CD44 interaction in SCC cells.
• Analysis of miR-34a and CD44 expression in relation to tumor stages, metastasis, and recurrence.

Main Results:

• Average levels of miR-34a and miR-34b/c were decreased in SCC patients.
• miR-34b/c showed earlier and more significant reduction than miR-34a.
• Both miR-34a and miR-34b/c inhibited SCC cell proliferation, migration, and invasion via the Notch1 pathway, with miR-34b/c having a stronger effect.
• miR-34a levels correlated significantly with CD44 levels in patients, and CD44 knockdown affected miR-34a's inhibitory roles.
• Overexpression of miR-34 inhibited tumor outgrowth in CD44-high cells, while anti-miR-34 promoted tumor development in CD44-low cells.

Conclusions:

• miR-34 family members act as negative regulators in SCC development.
• The inhibitory mechanisms involve multiple complex signaling pathways.
• These findings provide a theoretical basis for SCC treatment and identify miR-34 as a potential biomarker for SCC prognosis.